|
1 Indications And Usage Onivyde ® Is Indicated, In Combination With Fluorouracil And Leucovorin, For The Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas After Disease Progression Following Gemcitabine-Based Therapy. Limitation Of Use: Onivyde Is Not Indicated As A Single Agent For The Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas [See Clinical Studies (14) ] . Onivyde Is A Topoisomerase Inhibitor Indicated, In Combination With Fluorouracil And Leucovorin, For The Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas After Disease Progression Following Gemcitabine-Based Therapy. ( 1 ) Limitation Of Use: Onivyde Is Not Indicated As A Single Agent For The Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas. ( 1 )
|